# SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
> **ANDA220884** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2026-09-10
## Drug
- **FDA Application Number:** ANDA220884
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **First approval:** 2026-09-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220884)
---
*MORVS · CC0 1.0*